Oasmia Pharmaceutical AB | Mutual Funds
Mutual Funds that own Oasmia Pharmaceutical AB
SEB Sverige Indexfond
505,794
0.28%
-578,052
0.02%
12/31/2017
Skandia Sverige Exponering
81,412
0.05%
0
0.02%
07/31/2018
37,638
0.02%
0
0.01%
09/11/2018
Catella Sverige Index
22,368
0.01%
0
0.01%
08/31/2018
Skandia SMART Balanserad
15,032
0.01%
0
0%
07/31/2018
Skandia SMART Offensiv
9,699
0.01%
0
0%
07/31/2018
Handelsbanken Sverigefond Index
62
0%
-623,975
0%
08/31/2018
Handelsbanken Sverige Criteria
19
0%
-192,246
0%
08/31/2018
| Address |
Vallongatan 1
Uppsala UP 752 28
Sweden
|
|
Employees
|
- |
| Website |
http://www.oasmia.com |
| Updated |
07/08/2019 |
| Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden. |
